Zorubicin hydrochloride
Zorubicin hydrochloride is an anthracycline Antibiotic. Zorubicin hydrochloride exhibits activity against breast cancer, leukemia, and undifferentiated nasopharyngeal carcinoma. Zorubicin hydrochloride shows activity against undifferentiated nasopharyngeal carcinoma either as a monotherapy or in combination with Cisplatin (HY-17394). Zorubicin hydrochloride can be used in research related to breast cancer, leukemia, and undifferentiated nasopharyngeal carcinoma.
For research use only. We do not sell to patients.
- CAS No.: 36508-71-1
- Formula: C34H36ClN3O10
- Molecular Weight:682.12
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Antibiotic Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 36508-71-1
-
Molecular Weight 682.12
-
Formula C34H36ClN3O10
-
SMILES
OC1=C(C(C2=CC=CC(OC)=C2C3=O)=O)C3=C(O)C4=C1C[C@](/C(C)=N/NC(C5=CC=CC=C5)=O)(O)C[C@@H]4O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)N.Cl
-
Synonyms
Rubidazon hydrochloride; Rubidazone hydrochloride
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Bano N, et al. Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery. ACS omega. 2024 Jun 25;9(25):26762-26779. [Content Brief]
[2]. Jelić S, et al. Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT). Annals of oncology : official journal of the European Society for Medical Oncology. 1997 Aug;8(8):739-44. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)